Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

King Faisal Specialist Hospital & Research Center

Status: Completed

Conditions: Transitional Carcinoma of Urinary Bladder

Treatments: Drug: BCG, Interferon

Study type: Interventional

Funder types: Other

Identifiers

NCT00539773

RAC#2011-073

Details and patient eligibility

About

Phase II Trial of concurrent administration of intravesical BCG & Interferon in the treatment and prevention of recurrence of superficial transitional carcinoma of the urinary bladder.

Enrollment: 10 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with superficial transitional carcinoma of the urinary bladder

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)